戻る Agenda
[V6-S2] ARO Activities to Facilitate Late-Phase Clinical Trials in Asia
Session Chair(s)
Koichi Miyazaki, PHD
Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Evolution of the Clinical Trial Consortium in South Korea
Moo Hyun Kim, MD, PHD, FACC
Dong-A University, Korea, Republic of
Director, Global Clinical Trial Center
Clinical Trial Consortium in Taiwan
Kinwei Arnold Chan, DRSC, MD, FISPE
TriNetX, LLC, United States
Senior Vice President, Insight and Evidence Generation
ARO Activities to Facilitate Late-Phase Clinical Trial in Japan
Hideki Hanaoka, MD, PHD
Chiba University Hospital Clinical Research Center, Japan